The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
5018 2018 Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
2929 2015 Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
2838 2018 The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
2830 2015 Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC SS Ramalingam, J Vansteenkiste, D Planchard, BC Cho, JE Gray, Y Ohe, ...
New England Journal of Medicine 382 (1), 41-50, 2020
2547 2020 Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
2430 2018 Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
2282 2018 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients JE Gershenwald, W Thompson, PF Mansfield, JE Lee, MI Colome, ...
Journal of Clinical Oncology 17 (3), 976-976, 1999
1450 1999 Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy GR Varadhachary, EP Tamm, JL Abbruzzese, HQ Xiong, CH Crane, ...
Annals of surgical oncology 13, 1035-1046, 2006
1033 2006 Borderline resectable pancreatic cancer: the importance of this emerging stage of disease MHG Katz, PWT Pisters, DB Evans, CC Sun, JE Lee, JB Fleming, ...
Journal of the American College of Surgeons 206 (5), 833-846, 2008
954 2008 Branching Fraction and Photon Energy Spectrum for S Chen, JW Hinson, J Lee, DH Miller, V Pavlunin, EI Shibata, IPJ Shipsey, ...
Physical Review Letters 87 (25), 251807, 2001
946 2001 Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head DB Evans, GR Varadhachary, CH Crane, CC Sun, JE Lee, PWT Pisters, ...
Journal of Clinical Oncology 26 (21), 3496-3502, 2008
870 2008 Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer MA Kouvaraki, SE Shapiro, BD Fornage, BS Edeiken-Monro, SI Sherman, ...
Surgery 134 (6), 946-954, 2003
759 2003 Nanostructured materials for water desalination T Humplik, J Lee, SC O’hern, BA Fellman, MA Baig, SF Hassan, MA Atieh, ...
Nanotechnology 22 (29), 292001, 2011
748 2011 Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians YS Cho, CH Chen, C Hu, J Long, RT Hee Ong, X Sim, F Takeuchi, Y Wu, ...
Nature genetics 44 (1), 67-72, 2012
724 2012 Pancreaticoduodenectomy with vascular resection: margin status and survival duration JF Tseng, CP Raut, JE Lee, PWT Pisters, JN Vauthey, EK Abdalla, ...
Journal of Gastrointestinal Surgery 8, 935-950, 2004
697 2004 Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma CP Raut, JF Tseng, CC Sun, H Wang, RA Wolff, CH Crane, R Hwang, ...
Annals of surgery 246 (1), 52-60, 2007
689 2007 Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. FR Spitz, JL Abbruzzese, JE Lee, PW Pisters, AM Lowy, CJ Fenoglio, ...
Journal of Clinical Oncology 15 (3), 928-937, 1997
667 1997 Detectable clonal mosaicism from birth to old age and its relationship to cancer CC Laurie, CA Laurie, K Rice, KF Doheny, LR Zelnick, CP McHugh, ...
Nature genetics 44 (6), 642-650, 2012
661 2012 Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. JE Gershenwald, MI Colome, JE Lee, PF Mansfield, C Tseng, JJ Lee, ...
Journal of clinical oncology 16 (6), 2253-2260, 1998
629 1998 